Cantor Fitzgerald Weighs in on Xometry FY2024 Earnings

Xometry, Inc. (NASDAQ:XMTRFree Report) – Equities researchers at Cantor Fitzgerald raised their FY2024 earnings per share estimates for Xometry in a note issued to investors on Wednesday, November 6th. Cantor Fitzgerald analyst T. Jensen now anticipates that the company will earn ($0.68) per share for the year, up from their previous forecast of ($0.77). Cantor Fitzgerald currently has a “Underweight” rating and a $12.00 target price on the stock. The consensus estimate for Xometry’s current full-year earnings is ($0.79) per share.

A number of other equities research analysts also recently commented on the stock. The Goldman Sachs Group lifted their price target on shares of Xometry from $24.00 to $28.00 and gave the stock a “buy” rating in a report on Wednesday, November 6th. UBS Group boosted their price target on Xometry from $20.00 to $22.00 and gave the company a “neutral” rating in a report on Wednesday, November 6th. JMP Securities raised their price objective on Xometry from $27.00 to $32.00 and gave the stock a “market outperform” rating in a report on Friday, October 18th. Citigroup upped their target price on Xometry from $25.00 to $33.00 and gave the company a “buy” rating in a research note on Wednesday, November 6th. Finally, Craig Hallum raised their price target on Xometry from $20.00 to $30.00 and gave the stock a “buy” rating in a research note on Wednesday, November 6th. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and four have assigned a buy rating to the company. Based on data from MarketBeat, Xometry has an average rating of “Hold” and an average target price of $26.29.

Get Our Latest Analysis on XMTR

Xometry Trading Down 2.6 %

Shares of XMTR stock opened at $31.34 on Monday. The company has a market capitalization of $1.54 billion, a price-to-earnings ratio of -30.10 and a beta of 0.55. The company has a current ratio of 4.59, a quick ratio of 4.60 and a debt-to-equity ratio of 0.90. The firm has a 50-day moving average price of $20.02 and a 200 day moving average price of $16.95. Xometry has a twelve month low of $11.08 and a twelve month high of $38.74.

Hedge Funds Weigh In On Xometry

A number of hedge funds have recently made changes to their positions in XMTR. Raymond James & Associates boosted its position in Xometry by 0.6% during the 3rd quarter. Raymond James & Associates now owns 287,986 shares of the company’s stock worth $5,290,000 after purchasing an additional 1,586 shares during the period. Sei Investments Co. boosted its position in shares of Xometry by 0.8% in the second quarter. Sei Investments Co. now owns 214,048 shares of the company’s stock worth $2,474,000 after buying an additional 1,708 shares during the period. US Bancorp DE boosted its position in shares of Xometry by 57.7% in the third quarter. US Bancorp DE now owns 5,570 shares of the company’s stock worth $102,000 after buying an additional 2,037 shares during the period. State Board of Administration of Florida Retirement System grew its stake in shares of Xometry by 22.1% in the first quarter. State Board of Administration of Florida Retirement System now owns 11,840 shares of the company’s stock valued at $200,000 after buying an additional 2,140 shares in the last quarter. Finally, nVerses Capital LLC purchased a new stake in shares of Xometry during the 2nd quarter valued at about $38,000. Hedge funds and other institutional investors own 97.31% of the company’s stock.

Insider Activity at Xometry

In other Xometry news, CTO Matthew Leibel sold 3,400 shares of the company’s stock in a transaction dated Friday, September 13th. The stock was sold at an average price of $18.45, for a total transaction of $62,730.00. Following the completion of the sale, the chief technology officer now directly owns 82,918 shares in the company, valued at $1,529,837.10. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. In related news, Director Emily Rollins sold 3,729 shares of the firm’s stock in a transaction that occurred on Thursday, November 7th. The shares were sold at an average price of $29.49, for a total value of $109,968.21. Following the transaction, the director now owns 12,457 shares in the company, valued at approximately $367,356.93. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CTO Matthew Leibel sold 3,400 shares of Xometry stock in a transaction that occurred on Friday, September 13th. The shares were sold at an average price of $18.45, for a total transaction of $62,730.00. Following the transaction, the chief technology officer now directly owns 82,918 shares in the company, valued at approximately $1,529,837.10. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 41,633 shares of company stock worth $1,201,730. 16.79% of the stock is owned by insiders.

Xometry Company Profile

(Get Free Report)

Xometry, Inc operates an online marketplace that enables buyers to source custom-manufactured parts and assemblies in the United States and internationally. It provides computer numerical control manufacturing, sheet metal forming, and sheet cutting; 3D printing, including fused deposition modeling, direct metal laser sintering, PolyJet, stereolithography, selective laser sintering, binder jetting, carbon digital light synthesis, multi jet fusion, and lubricant sublayer photo-curing; and die casting, stamping, injection molding, urethane casting, tube cutting, and tube bending, as well as finishing services, rapid prototyping, and high-volume production services.

Featured Articles

Receive News & Ratings for Xometry Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xometry and related companies with MarketBeat.com's FREE daily email newsletter.